PRESS

MEDIA KIT

Press inquiries, brand assets, and facts sheet. For interviews on South African cannabis retail, CBD market trends, or Section 21 telemedicine workflows, use the contact below — we respond within one business day.

FACTS SHEET

Who we are, in one page

FOUNDED

2025

HEADQUARTERED

Cape Town, South Africa

SERVES

All 9 SA provinces

FULFILMENT

Courier Guy · Aramex · Fastway

PRODUCT TRACKS

Schedule-0 CBD · Section 21 cannabis

CLINICAL PARTNER

Docto24 telemedicine platform

LAB ACCREDITATION

SANAS ISO 17025

REGULATORY FRAMEWORK

SAHPRA · HPCSA · POPIA

TOPICS WE COVER

What we can speak to on record

• The South African CBD & cannabis market

  We can speak to consumer-CBD growth, Schedule-0 limits under Gazette 43347, how Section 21 access works for medical cannabis, and where the regulatory boundaries currently sit.

• Lab-testing + product transparency

  Concrete data on batch-testing protocols, what SANAS ISO 17025 accreditation actually requires, and common gaps in competitor COA practices.

• Compliance-first e-commerce

  How a direct-to-consumer cannabis shop operates inside §18C (Medicines Act) and HPCSA Rule 27 advertising limits — the trade-offs between SEO and compliance.

• Telemedicine + pharmacy routing

  How Cannabuben routes prescription items to HPCSA-registered doctors via Docto24 and onward to licensed dispensing pharmacies. The paper-trail audit model.

USING OUR NAME

Brand-mention guidelines

• · Our name is Cannabuben (one word, capital "C"). Never hyphenated, never all-caps in running prose.
• · Primary colour is the neon green #00FF66 on a deep charcoal background. Logo assets available on request.
• · We are a retailer, not a clinic. Clinical consultations happen on our sister brand Docto24. Please credit both where relevant.
• · We sell consumer CBD (Schedule 0) and prescription cannabis (Section 21) — please distinguish these clearly in reporting. They are different products, different regulatory tracks, and mixing them up causes reader confusion.

RECENT COVERAGE

In the media

We're a young brand — coverage is modest so far. This list will grow. If you've written about Cannabuben and would like the link added here, email press@cannabuben.co.za.